|
Volumn 46, Issue 2, 2002, Pages 478-486
|
Phosphorylation of β-D-ribosylbenzimidazoles is not required for activity against human cytomegalovirus
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
2 BROMO 5,6 DICHLORO 1 (BETA DEXTRO RIBOFURANOSYL)BENZIMIDAZOLE;
2 BROMO 5,6 DICHLORO 1 (BETA DEXTRO RIBORUFANOSYL)BENZIMIDAZOLE 5' MONOPHOSPHATE;
2,5,6 TRICHLORO 1 (BETA DEXTRO RIBOFURANOSYL)BENZIMIDAZOLE;
5' DEOXY 2,5,6 TRICHLORO 1 (BETA DEXTRO RIBOFURANOSYL)BENZIMIDAZOLE;
ALKALINE PHOSPHATASE;
ANTIVIRUS AGENT;
BENZIMIDAZOLE DERIVATIVE;
DRUG METABOLITE;
RIBONUCLEOSIDE DERIVATIVE;
UNCLASSIFIED DRUG;
ANION EXCHANGE CHROMATOGRAPHY;
ANTIVIRAL ACTIVITY;
ARTICLE;
CYTOMEGALOVIRUS INFECTION;
DNA SYNTHESIS INHIBITION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG METABOLISM;
DRUG POTENCY;
DRUG SELECTIVITY;
HUMAN;
HUMAN CELL;
HUMAN CYTOMEGALOVIRUS;
NONHUMAN;
PHOSPHORYLATION;
PRIORITY JOURNAL;
REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
VIRUS GENOME;
VIRUS INHIBITION;
ANTIVIRAL AGENTS;
BENZIMIDAZOLES;
CYTOMEGALOVIRUS;
DNA;
DRUG RESISTANCE, MICROBIAL;
HUMANS;
PHOSPHORYLATION;
RIBONUCLEOSIDES;
RNA;
TUMOR CELLS, CULTURED;
|
EID: 0036150159
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.46.2.478-486.2002 Document Type: Article |
Times cited : (31)
|
References (46)
|